Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for Geographic Atrophy (GA)
Sites in Reno +55 more locations
Sponsor: ONL Therapeutics
Sex: All·Age: 55+
Code: NCT06659445·Phase 2·Recruiting·Listed Oct 2024
Clinical Trials at Sierra Eye Associates
As of September 2026, 15 paid clinical trials are recruiting at Sierra Eye Associates, located at 505 S ARLINGTON AVE STE 106, RENO, NV 89509-1505, phone (775) 391-0444 in Reno, Nevada. Active studies at this site cover conditions such as Geographic Atrophy, Malignant Solid Neoplasm and Metastatic Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
15 clinical trials at Sierra Eye Associates
·Clear filters· Get a weekly email when new trials open in Reno, NV.
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
Drug: Surabgene Lomparvovec
Sites in Reno +52 more locations
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07007065·Phase 3·Recruiting·Listed Jun 2025
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for Geographic Atrophy
Sites in Reno +44 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 60+
Code: NCT06635148·Phase 2, Phase 3·Recruiting·Listed Oct 2024
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
for Neovascular Age-Related Macular Degeneration (nAMD)
Sites in Reno +53 more locations
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT07064759·Phase 3·Recruiting·Listed Jul 2025
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
for Diabetic Retinopathy
Drug: Surabgene Lomparvovec
Sites in Reno +31 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT07592273·Phase 2, Phase 3·Recruiting·Listed May 2026
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for Geographic Atrophy
Sites in Reno +27 more locations
Sponsor: Sanofi
Sex: All·Age: 60+
Code: NCT07215234·Phase 1, Phase 2·Recruiting·Listed Oct 2025
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
for Macular Edema
Sites in Reno +36 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06962839·Phase 2·Recruiting·Listed May 2025
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
for Geographic Atrophy
Sites in Reno +14 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 50+
Code: NCT05626114·Phase 2·Recruiting·Listed Nov 2022
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
for Neovascular (Wet) Age-Related Macular Degeneration
Sites in Reno +19 more locations
Sponsor: 4D Molecular Therapeutics
Sex: All·Age: 50+
Code: NCT05197270·Phase 1, Phase 2·Recruiting·Listed Jan 2022
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Sites in Reno +3 more locations
Sponsor: Complement Therapeutics
Sex: All·Age: 55+
Code: NCT07392255·Phase 1, Phase 2·Recruiting·Listed Feb 2026
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
for Geographic Atrophy Secondary to Age-related Macular Degeneration
Sites in Reno +5 more locations
Sponsor: Complement Therapeutics
Sex: All·Age: 55+
Code: NCT07144137·Recruiting·Listed Aug 2025
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
for Age-Related Macular Degeneration
Sites in Reno +6 more locations
Sponsor: i-Lumen Scientific AUS PTY LTD
Sex: All·Age: 60+
Code: NCT06662162·Recruiting·Listed Oct 2024
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
for Geographic Atrophy
Sites in Reno +4 more locations
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07160179·Phase 1, Phase 2·Recruiting·Listed Sep 2025
Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
for Diabetic Macular Edema
1 location in Reno
Sponsor: Sierra Eye Associates
Sex: All·Age: 25 - 89
Code: NCT06942520·Phase 2·Recruiting·Listed Apr 2025
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
for Geographic Atrophy
Sites in Reno +10 more locations
Sponsor: Biojiva LLC
Sex: All·Age: 55+
Code: NCT07029945·Phase 1, Phase 2·Recruiting·Listed Jun 2025
Common conditions studied in Reno
- Geographic Atrophy (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Metastatic Breast Cancer (5 active studies)
- Non-small Cell Lung Cancer (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
- Breast Cancer (4 active studies)
Leading research sponsors in Reno
- AbbVie
- Children's Oncology Group
- Alliance for Clinical Trials in Oncology
- Merck Sharp & Dohme LLC
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Reno?
There are approximately 166 recruiting clinical trials in Reno, Nevada listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Reno pay participants?
Most recruiting trials in Reno compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Reno?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Reno?
The most common conditions under active study in Reno include Geographic Atrophy (5), Malignant Solid Neoplasm (5), Metastatic Breast Cancer (5), Non-small Cell Lung Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Reno?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Reno on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Reno?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Reno?
Recruiting research sites in Reno include Renown Regional Medical Center, Sierra Eye Associates, Saint Mary's Regional Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Reno right now?
The largest active categories in Reno are Cancer & tumors (80), Eye & vision (15), Neurology & pain (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Sierra Eye Associates?
Sierra Eye Associates is located at 505 S ARLINGTON AVE STE 106, RENO, NV 89509-1505. Use the Google Maps link in the intro above to get directions.
How do I contact Sierra Eye Associates?
You can reach Sierra Eye Associates by phone at (775) 391-0444. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.